Literature DB >> 32187111

Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections.

Laura R Marks, Stephen Y Liang, Michael J Durkin1, Marlene Martin2, Katie D White3, Isaac See4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32187111      PMCID： PMC7487013          DOI： 10.1097/ADM.0000000000000650

Source DB:  PubMed          Journal:  J Addict Med        ISSN： 1932-0620            Impact factor:   4.647


× No keyword cloud information.
  4 in total

1.  Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs.

Authors:  Joji Suzuki; Jennifer A Johnson; Mary W Montgomery; Margaret C Hayden; Christin N Price; Daniel A Solomon; Jane M Liebschutz; Jeffrey L Schnipper; Roger D Weiss
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

2.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

Authors:  Jane M Liebschutz; Denise Crooks; Debra Herman; Bradley Anderson; Judith Tsui; Lidia Z Meshesha; Shernaz Dossabhoy; Michael Stein
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

3.  Addiction Medicine Consultations Reduce Readmission Rates for Patients With Serious Infections From Opioid Use Disorder.

Authors:  Laura R Marks; Satish Munigala; David K Warren; Stephen Y Liang; Evan S Schwarz; Michael J Durkin
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

Review 4.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26
  4 in total
  4 in total

1.  Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply.

Authors:  Joji Suzuki; Jennifer A Johnson; Mary W Montgomery; Margaret C Hayden; Christin N Price; Daniel A Solomon; Jane M Liebschutz; Jeffrey L Schnipper; Roger D Weiss
Journal:  J Addict Med       Date:  2020-12       Impact factor: 4.647

2.  Low Knowledge of HIV PrEP Within a Midwestern US Cohort of Persons who Inject Drugs.

Authors:  Sena Sayood; Laura R Marks; Rupa Patel; Nathanial S Nolan; Stephen Y Liang; Michael J Durkin
Journal:  Open Forum Infect Dis       Date:  2021-11-10       Impact factor: 3.835

3.  Use of ICD-10 Codes for Identification of Injection Drug Use-Associated Infective Endocarditis Is Nonspecific and Obscures Critical Findings on Impact of Medications for Opioid Use Disorder.

Authors:  Laura R Marks; Nathanial S Nolan; Linda Jiang; Dharushana Muthulingam; Stephen Y Liang; Michael J Durkin
Journal:  Open Forum Infect Dis       Date:  2020-09-09       Impact factor: 3.835

4.  Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic: A Qualitative Analysis.

Authors:  Emily Gleason; Nathanial S Nolan; Laura R Marks; Tracey Habrock; Stephen Y Liang; Michael J Durkin
Journal:  J Addict Med       Date:  2022 Mar-Apr 01       Impact factor: 3.702
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.